Rho Ventures Vi Lp - Net Worth and Insider Trading

Rho Ventures Vi Lp Net Worth

The estimated net worth of Rho Ventures Vi Lp is at least $1 Million dollars as of 2024-11-13. Rho Ventures Vi Lp is the 10% Owner of Cara Therapeutics Inc and owns about 3,568,057 shares of Cara Therapeutics Inc (CARA) stock worth over $1 Million. Details can be seen in Rho Ventures Vi Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rho Ventures Vi Lp has not made any transactions after 2017-03-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Rho Ventures Vi Lp

To

Rho Ventures Vi Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rho Ventures Vi Lp owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Everyday Health Inc (EVDY) .

Click here to see the complete history of Rho Ventures Vi Lp’s form 4 insider trades.

Insider Ownership Summary of Rho Ventures Vi Lp

Ticker Comapny Transaction Date Type of Owner
CARA Cara Therapeutics Inc 2017-03-31 10 percent owner
EVDY Everyday Health Inc 2016-12-03 10 percent owner

Rho Ventures Vi Lp Latest Holdings Summary

Rho Ventures Vi Lp currently owns a total of 1 stock. Rho Ventures Vi Lp owns 3,568,057 shares of Cara Therapeutics Inc (CARA) as of March 31, 2017, with a value of $1 Million.

Latest Holdings of Rho Ventures Vi Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CARA Cara Therapeutics Inc 2017-03-31 3,568,057 0.34 1,200,294

Holding Weightings of Rho Ventures Vi Lp


Rho Ventures Vi Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Rho Ventures Vi Lp has made a total of 0 transactions in Cara Therapeutics Inc (CARA) over the past 5 years. The most-recent trade in Cara Therapeutics Inc is the acquisition of 500,000 shares on March 31, 2017, which cost Rho Ventures Vi Lp around $9 Million.

Insider Trading History of Rho Ventures Vi Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rho Ventures Vi Lp Trading Performance

GuruFocus tracks the stock performance after each of Rho Ventures Vi Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rho Ventures Vi Lp is -7.65%. GuruFocus also compares Rho Ventures Vi Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rho Ventures Vi Lp within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rho Ventures Vi Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rho Ventures Vi Lp

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.23 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.7 LIMIT LIMIT LIMIT LIMIT LIMIT

Rho Ventures Vi Lp Ownership Network

Ownership Network List of Rho Ventures Vi Lp

No Data

Ownership Network Relation of Rho Ventures Vi Lp

Insider Network Chart

Rho Ventures Vi Lp Owned Company Details

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Rho Ventures Vi Lp is the 10 percent owner of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Rho Ventures Vi Lp made no insider transaction in Cara Therapeutics Inc (CARA). Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 60,412 shares made by Christopher Posner , a net sale of 5,476 shares made by Joana Goncalves , and a net sale of 5,236 shares made by Scott Terrillion .

In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 74,117 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 74,117 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cara Therapeutics Inc Insider Transactions

No Available Data

Rho Ventures Vi Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Rho Ventures Vi Lp. You might contact Rho Ventures Vi Lp via mailing address: 152 West 57th Street, 23rd Floor, New York Ny 10019.